SCIOTO BIOSCIENCES
Scioto Biosciences is a developer of Activated Bacterial Therapeutics (ABT) platform intended to deliver live bacteria to the gut. The company is developing innovative therapies devoted to having a transformative impact on the delivery of microbiome therapeutics, enabling medical practitioners to advance healing through microbiome therapeutics.
SCIOTO BIOSCIENCES
Industry:
Biotechnology Diabetes Health Care Life Science Therapeutics
Founded:
2017-01-01
Address:
Indianapolis, Indiana, United States
Country:
United States
Website Url:
http://www.sciotobiosciences.com
Total Employee:
51+
Status:
Active
Contact:
+1 866 672 4686
Total Funding:
30.96 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Advisors List
Current Employees Featured
Founder
Investors List
Genome & Co.
Genome & Co. investment in Series B - Scioto Biosciences
National Institutes of Health
National Institutes of Health investment in Grant - Scioto Biosciences
IU Angel Network
IU Angel Network investment in Series A - Scioto Biosciences
Pathway Bioventures
Pathway Bioventures investment in Series A - Scioto Biosciences
BioCrossroads
BioCrossroads investment in Series A - Scioto Biosciences
Elevate Ventures
Elevate Ventures investment in Series A - Scioto Biosciences
Rev1 Ventures
Rev1 Ventures investment in Series A - Scioto Biosciences
National Institutes of Health
National Institutes of Health investment in Grant - Scioto Biosciences
BioCrossroads
BioCrossroads investment in Grant - Scioto Biosciences
Official Site Inspections
http://www.sciotobiosciences.com
- Host name: 182.247.196.104.bc.googleusercontent.com
- IP address: 104.196.247.182
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Scioto Biosciences"
About - Scioto Biosciences, Inc.
Mr. Schulz is a serial entrepreneur with over 20 years of financial experience working with public accounting firms, Fortune 500 companies and small start-up companies.See details»
Scioto Biosciences - Crunchbase Company Profile & Funding
Scioto Biosciences is a developer of Activated Bacterial Therapeutics (ABT) platform intended to deliver live bacteria to the gut. The company is developing innovative therapies devoted to …See details»
Contact - Scioto Biosciences, Inc.
Corporate HQ. Scioto Biosciences, Inc. 9800 Crosspoint Blvd Indianapolis, IN 46256. Research Labs. Scioto Biosciences, Inc. Indiana Center for Biomedical InnovationSee details»
Scioto Biosciences Company Profile | Management and ... - Datanyze
Www.sciotobiosciences.com Scioto Biosciences Profile and History Based in Indianapolis, Scioto Biosciences is a clinical stage company developing innovative therapies devoted to having a …See details»
Scioto Biosciences, Inc - LinkedIn
Scioto Biosciences, Inc | 971 followers on LinkedIn. Scioto Biosciences is a Clinical stage biotech company dedicated to innovative research and discovery in the field of microbiome therapeutics.See details»
Scioto Biosciences Inc. Company Profile | Indianapolis, IN ...
Find company research, competitor information, contact details & financial data for Scioto Biosciences Inc. of Indianapolis, IN. Get the latest business insights from Dun & Bradstreet.See details»
Scioto Biosciences - PitchBook
Scioto Biosciences General Information Description. Operator of a clinical-stage biotech company intended to be used for research, discovery, and development in the field of microbiome therapeutics.See details»
Scioto Biosciences - Craft
Scioto Biosciences has 5 employees across 2 locations and $30.96 m in total funding,. See insights on Scioto Biosciences including office locations, competitors, revenue, financials, …See details»
Scioto Biosciences - Overview, News & Similar companies
Apr 3, 2023 Scioto Biosciences contact info: Phone number: (317) 652-1840 Website: www.sciotobiosciences.com What does Scioto Biosciences do? Based in Indianapolis, Scioto …See details»
Scioto - VentureRadar
Vaiomer France Privately Held Vaiomer is a biotech company and contract research organization (CRO) expert in tissue and blood microbiota. The company was created in 2011 on the …See details»
Scioto Biosciences Receives Series B Investment from Genome
Aug 11, 2020 Scioto Biosciences announces a strategic investment of up to $26.5M from Genome & Company and other investors to join in an upcoming tranche.See details»
Working at Scioto - Scioto Biosciences, Inc.
Scioto Biosciences has its corporate offices in Fishers, Indiana located at the Club at Crosspoint and our research facilities are located as part of the Indiana Center for Biomedical Innovation.. …See details»
THE ROLE OF BIOFILMS: An Interview with Scioto Biosciences
Aug 3, 2018 Our focus turns to biofilms and with the expertise of Scioto Biosciences, a preclinical stage company devoted to having a transformative impact on the delivery of …See details»
Scioto Biosciences, Inc. Announces Top-Line Results of SB-121 in a ...
May 26, 2022 FISHERS, Ind.--(BUSINESS WIRE)--Scioto Biosciences, Inc. (Scioto), a clinical-stage biotechnology company dedicated to innovative research and development in the field of …See details»
Investors & News - Scioto Biosciences, Inc.
SB-121 is one of the most exciting programs in the microbiome space. Scioto’s Phase Ib in patients with Autism is an excellent proof-of-concept and an enormous step forward.See details»
Scioto Biosciences Announces Publication of Phase 1b Study in …
Apr 3, 2023 Joe Trebley, CEO (866) 672-4686 [email protected]. #Hashtags. #autism; #microbiome; #autismawareness; #gutbrainaxis; Social Media Profiles. Scioto on …See details»
ABT Platform - Scioto Biosciences, Inc.
Microbiome research and development is greatly influencing the way we now treat a wide range of diseases and conditions. While there are several “probiotic” products sold over the counter …See details»
Scioto Biosciences, Inc. Announces First Patient Dosed in Phase Ib ...
Aug 18, 2021 INDIANAPOLIS--(BUSINESS WIRE)--Scioto Biosciences, Inc. announced the beginning of their Phase Ib clinical trial for their lead investigational product SB-121 for the …See details»
Press Release Archives - Scioto Biosciences, Inc.
Press Release Scioto Biosciences and Abigail Wexner Research Institute at Nationwide Children’s Hospital Receive a $2.3 Million Dollar Phase II SBIR Grant to Develop Novel TherapySee details»